GlaxoSmithKline (GSK)

44.38 +0.10  +0.23%  May 29, 5:19PM Go Pro
You must be signed in to use watchlists.
Sign In or Register
Watch this stock

GlaxoSmithKline Performance

Historical performance is a good guide for the future, but it is imperfect. Pay attention to a company's history, but be realistic about what you can project into the future.

5 Year Total Returns Performance

Returns from price appreciation only give a partial view of the returns to an investor. This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested)

Returns -15.82%
Total Returns 8.83%

1 Year Total Returns Performance Comparison

Here are GlaxoSmithKline's total returns compared to the market and some of its peers. High historical total returns are excellent - especially if you held the stock at the time - but returns can change direction quickly. To predict future performance, looking at the business is more important than looking at historic returns.

  • GSK Total Returns
  • ^SPXTR Total Returns
  • PFE Total Returns
  • NVS Total Returns
1 month total returns YTD total returns 1 year total returns* 3 year total returns
GSK -3.44% 0.23% 7.76% 54.45%
^SPXTR -5.89% 5.70% 1.18% 54.61%
PFE -2.95% 4.59% 10.44% 66.56%
NVS -5.03% -4.52% -13.48% 47.44%

* May differ from chart if one year ago today was not a trading day. Table uses the previous trading day as a base while chart uses the next trading day.

Fundamental Performance

Price vs Earnings

In the long run, the price and earnings of a company are correlated. If the two metrics are diverging, there should be a good reason why. Divergence without reason can signal danger or opportunity.

Price -15.82%
Earnings Per Share TTM -4.20%

Earnings Yield vs Dividend Yield

Yields show how much you are getting for the price you pay. For example, an earnings yield of 8% means that for every dollar you pay, you get 8 cents worth of current earnings. Take these numbers into account when buying to see if you are over-paying or getting a good deal.

Earnings Yield 7.19%
Dividend Yield 4.99%

Revenue and Earnings Growth

Revenues show how much the company is selling to customers, while net income is what remains for shareholders after the company pays its expenses. Revenue growth often persists over time, but net income is more fickle. Watch closely to see if revenue and income grow at similar rates.

Revenues TTM 43.96B
Net Income TTM 8.104B

Efficent Use of Assets

Profit margins show what percentage of every dollar of sales turns into earnings. Asset Uitlization shows how many dollars of sales a company gets for each dollar that the company invests in assets. Multiplying the two numbers together gives you Return on Assets which tells you approximately how efficiently the company invests money to earn more money.

Profit Margin 19.95%
Asset Utilization 0.6623

Reinvestment Strategy

Return on Invested Capital (ROIC) tells you how much income a company earned after investing $1 in its business. The Payout Ratio tells what percentage of the company's income it pays to shareholders instead of reinvesting in its own growth. Watch out for companies that pay out very little when their ROIC is low.

5 Year Average ROIC 0.2153
5 Year Average Payout Ratio 0.8081

You may also be interested in these GSK related companies

Get Performance for
Display in Live Stream: Done
Options

GSK News

@mydanilo It had nothing to do with those news. That was already priced in. Seems like Patent news regarding $TEVA and $GSK was the trigger.
about 7 hours ago by mitrado
$AMRN up following news that $Teva and $PRX lost a bid to sell the generic form of $GSK Lovaza. http://stks.co/41F0
about 8 hours ago by abubnic
Auxilium Pharma Sues Watson
May 29, 12:45PM
Teva Issues 2012 Outlook
May 29, 11:00AM
4 Stocks Buffett May Be Buying in Europe
May 25, 12:21PM Investor Place
Finding a Pathway to Approval
May 24, 2:53PM Fool
$GSK reacts to $HGSI poison pill. Stubborn, or what? It seems they do not want to get pushed or pulled.
about 7 days ago by OysterX
20 Giants for a 6% Dividend Yield
May 21, 9:07AM Fool
@xjun "totally betrayed" $AMRN says: "Sorry, it's not personal. Look at some of my neighbours: $ONTY, $SPPI, $NVAX, $GSK, $TEVA, $CELG ..."
about 12 days ago by mitrado
Why U.K. Bonds Are for Losers
May 17, 6:07PM Fool
Still think that $GSK will not succeed with $HGSI takeover at 13/share. They will increase the offer price, but probably not above 15.
about 13 days ago by OysterX
News related to $GSK, currently 0.0% since open: 'Prestige Brands posts small fiscal 4Q loss' http://stks.co/3s9V
about 13 days ago by TradeBot
Gilead Sciences’ HIV Drugs Clear a Hurdle
May 17, 10:00AM Investor Place
$GSK Trametinib also in the spotlight at ASCO '12 with six presentations over 4 days. http://stks.co/3roL
about 13 days ago by abubnic
$GSK Dabrafenib getting its share of attention at ASCO '12 with 50 presentations over 4 days. http://stks.co/3roI
about 13 days ago by abubnic
$PFE $LLY $GSK So this is the condition some drug commercials warned us about! And we thought they were kidding. http://stks.co/3q2n
about 14 days ago by laughing_stock
Don't see $XNPT popping 100% like $ARNA did, not as glamorous and still has to settle with $GSK. They would get 10 million if still partnrd
about 14 days ago by Glopolon
5 Dividends to Reinvest
May 14, 10:34AM Fool
$ARNA -Big brand name companies may be interested in buyout $GSK $PFE $SNY $ABT First weight-loss drug in US may be approved in June $SPY $$
about 16 days ago by peterumble
$XNPT, No Debt, Drug has already been approved for RLS, so safety issues known. Court case with $GSK still out there, want settlement.
about 18 days ago by Glopolon
Some really tempting European stocks that pay healthy dividends $SNY $HBC $SI $ABB $SNY $GSK $RDS.B all above 4%
about 20 days ago by sld1986
$VVUS Racked With Losses, Vivus is Putting All Its Eggs in This Basket http://stks.co/3kNz $OREX $ARNA $PFE $LLY $GSK
about 20 days ago by DrNick
RT @JasonMilano8 $AMRN Here is a news about current CEO of Amarin selling his former company Reliant to ($GSK) in 2007: http://stks.co/3k0G
about 21 days ago by JasonMilano8
Breakfast Links | via @PointsnFigures http://stks.co/3jto $AMZN $GSK $HGSI $ZNGA
about 21 days ago by STNet
That's a surprise. $GSK goes hostile with $HGSI offer at 13. Did not expect that and am curious whether HGSI has something up its sleeve.
about 21 days ago by OysterX
$AMRN Here is a news about current CEO of Amarin selling his former company Reliant to GlaxoSmithKline ($GSK) in 2007: http://stks.co/3jYt
about 21 days ago by JasonMilano8
$XNPT, Only non-dopaminergic option for RLS, is the advantage over generics. If $XNPT can work things out with $GSK, this should be $5+
about 21 days ago by Glopolon
Huf Post: Two Drugs Harness Immune System To Fight Cancer. http://stks.co/3iDa $DNDN $BMY $AZN $ONTY $GSK
about 22 days ago by abubnic
@BioRunUp @GantosJ $XNPT, Hope that they can settle w/ $GSK, and if Astellas in Japan is competent, then $XNPT is looking good.
about 22 days ago by Glopolon
$XNPT Sounds like Astellas is going to be better partner than $GSK, Hope they can work things out with $GSK re: Horizant.
about 23 days ago by Glopolon
$XNPT $GSK, FDA PDUFA date June 9th for Horizant treating postherpetic neuralgia. Horizant already approved in Japan for restless leg synd.
about 26 days ago by Glopolon
Best Yielding Large Cap Healthcare Stocks + http://stks.co/3cMJ + $JNJ $PFE $NVS $MRK $GSK $SNY $NVO $UNH $BMY $TEVA $MDT $BAX $AGN $SYK
about 28 days ago by DividendYield

Recent Quotes

Symbol Price Chg Chg % Market Cap
GSK 44.38 +0.10 +0.23% 111.75B
GSIT 4.18 -0.02 -0.48% 120.25M
GSIG 11.98 +0.13 +1.10% 397.09M
GSI 0.9874 +0.12 +13.48%
GSH 16.41 +0.11 +0.67% 2.314B
GSB 2.06 -0.09 -4.19% 39.15M
GSAT 0.391 -0.01 -3.43% 120.61M
GS 97.82 +1.12 +1.16% 47.86B
GRZ 3.40 +0.11 +3.34% 195.89M
GRX 8.14 +0.04 +0.49%
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close